Amyloid-Journal of Protein Folding Disorders

Papers
(The H4-Index of Amyloid-Journal of Protein Folding Disorders is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee266
Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee105
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial104
Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis58
ATTRv amyloidosis Italian Registry: clinical and epidemiological data52
Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis50
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines45
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation40
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis32
Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding30
Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen25
Association between spinal stenosis and wild-type ATTR amyloidosis25
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group24
Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging23
Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma23
Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies23
Tissue biopsy for the diagnosis of amyloidosis: experience from some centres22
Next generation flow cytometry for MRD detection in patients with AL amyloidosis22
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients19
TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients19
0.031474113464355